Search

Search Constraints

You searched for: Author/Creator Izutsu, Koji

Search Results

1. A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma. Issue 3 (4th December 2019)

2. A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström's macroglobulinemia. Issue 9 (20th July 2020)

3. A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma. (5th January 2016)

4. A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma. Issue 7 (4th June 2021)

5. A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia. (27th November 2020)

6. Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15‐MKL1 in an adult patient following a non‐mediastinal germ cell tumour. (23rd June 2020)

7. Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population‐based cancer registry data in Japan from 1993 to 2006. Issue 5 (26th February 2015)

8. Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B‐cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry. (29th July 2019)

9. Association of CD204+ macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT. (8th October 2019)

10. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital. Issue 1 (December 2016)